Vishal Patel
Interventional Pain Medicine · de Pere, WINPI 1619313475
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Abbott at 37.0% of the total. 2025 is the largest year on record at $10,773, 5.3 times the $2,042 reported in 2019.
Across 321 payments — averaging $72.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$9K
- SPR Therapeutics, Inc$8K
- Relievant Medsystems, Inc.$1K
- Si-bone, Inc.$1K
- Medtronic$979
- Bioventus LLC$517
- plus $3K from 17 others
What the payments were for
- Consulting fees$4,42519%
- Travel & lodging$5,68725%
- Food & beverage$13,09056%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 173 | $8,576 |
| SPR Therapeutics, Inc | 67 | $7,763 |
| Relievant Medsystems, Inc. | 7 | $1,421 |
| Si-bone, Inc. | 5 | $1,105 |
| Medtronic(2 entities) | 17 | $979 |
| Bioventus LLC | 4 | $517 |
| Nalu Medical, Inc. | 5 | $415 |
| Boston Scientific | 7 | $398 |
| MML US, Inc. | 6 | $374 |
| Gilead | 4 | $301 |
| Vertos Medical, Inc. | 5 | $264 |
| Nevro Corp. | 2 | $259 |
| Curonix LLC | 2 | $177 |
| Saluda Medical Americas, Inc. | 2 | $169 |
| Stryker | 1 | $158 |
| GRT US Holding, Inc. | 1 | $130 |
| Tersera Therapeutics LLC | 3 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $38 |
| Novartis | 2 | $30 |
| Amgen | 2 | $27 |
| Spinal Simplicity, LLC | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Sight Sciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$7,116
- PROCLAIM$4,335
- Intracept$2,608
- Proclaim Family of SCS IPGs$2,043
- IFUSE IMPLANT SYSTEM$825
- Nalu Neurostimulation System$370
- Stimrouter Implantable Kit$369
- ReActiv8$287
- INTELLIS ADAPTIVESTIM$269
- Proclaim IPG$223
- Omnia$189
- mild Device Kit$158
- Vanta$148
- GENERAL PAIN MANAGEMENT$134
- S-Series SCS Leads$133
- Qutenza$130
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$123
- Evoke SCS$105
How this compares
$23,210 in reported general payments places this provider in the 85th percentile of 41 interventional pain medicine providers in Wisconsin.
See all interventional pain medicine providers in Wisconsin →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 121 | $2,075 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 132 | $1,577 |
| Gabapentin | 110 | $1,561 |
| Diclofenac Sodium | 141 | $1,165 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 88 | $1,132 |
| Tizanidine Hcl | 115 | $939 |
| Duloxetine Hcl | 50 | $684 |
| Cyclobenzaprine Hcl | 75 | $448 |
| Morphine Sulfate ErMorphine Sulfate | 14 | $419 |
| Methylprednisolone | 48 | $320 |
| Oxycodone Hcl | 17 | $274 |
| Methocarbamol | 27 | $258 |
| Celecoxib | 12 | $236 |
| Tramadol Hcl | 40 | $203 |
| Topiramate | 21 | $143 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in de Pere
- Hind Gautamde Pere$284
- Christopher HowsonGreen Bay$114K
- Matthew PileckiMount Pleasant$29K
- Christina MooreMilwaukee$26K
- Nileshkumar PatelGreenfield$25K
- Daniel BrunnerNeenah$24K
- Colin StairSummit$17K
- Timothy StaackeKenosha$13K
- Richard LennertzMilwaukee$11K
- Ryan ClarkGreen Bay$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.